Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Osteosarcoma 1NSCLC 1Advanced Squamous Non-Small-Cell Lung Cancer 1

Interventions

Methotrexate 5Drug Therapy 5apatinib 4Neoadjuvant Therapy 4Doxorubicin 3camrelizumab 2Ifosfamide 2Cisplatin 2trilaciclib 1spartalizumab 1palbociclib 1isophosphamide mustard 1irinotecan sucrosofate 1glucarpidase 1endostar protein 1Zoledronic Acid 1Vinorelbine 1Triptorelin Pamoate 1Trabectedin 1Therapeutics 1Thalidomide 1TQ-B3525 1Psychiatric Rehabilitation 1Nivolumab 1Neuropsychological Tests 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Microbiota 1Metabolome 1Magnetic Resonance Spectroscopy 1Lithium Carbonate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Osteosarcoma × trilaciclib × Clear all
NCT06217003 2024-01-22

Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma

The First Affiliated Hospital of Xinxiang Medical College

Phase 2 Unknown
20 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡